ANTX
#3727
AN2 Therapeutics, Inc. - Common Stock
4.7 6 USD
+0.05%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+4.62%
Monthly Change
-3.45%
6 month change
+274.80%
Year Change
+349.06%
Previous Close
4.5 5
Open
4.7 6
Low
4.7 6
High
4.7 6
Volume
74
Financials
- Market Capitalization 171.44 M
- Employee 21
- Founded 2017
- CEO N/A
- Website www.an2therapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QYLYBK4
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3715 |  EQ Equillium, Inc. - Common Stock | 2.76 USD | -4.17% | -2.82% | -2.13% | +607.69% | 174.51 M USD | ||
| 3719 |  CRBU Caribou Biosciences, Inc. - Common Stock | 1.75 USD | -2.78% | -7.41% | +5.42% | +5.42% | 173.57 M USD | ||
| 3730 |  ADAG Adagene Inc - ADS, each representing 1.25 | 3.61 USD | -5.50% | -8.38% | +1.40% | +103.95% | 171.06 M USD | ||
| 3731 |  IPHA Innate Pharma S.A. - American Depositary Shares | 1.82 USD | +1.68% | -0.55% | -1.09% | +1.11% | 170.57 M USD |
Frequently asked questions about AN2 Therapeutics, Inc. - Common Stock
What is the AN2 Therapeutics, Inc. - Common Stock stock price today?
The current price of AN2 Therapeutics, Inc. - Common Stock (ANTX) is 4.76. Over the past 24 hours, the stock has changed by +4.62%. Follow the ANTX chart for real-time price dynamics.
What is the stock ticker of AN2 Therapeutics, Inc. - Common Stock?
AN2 Therapeutics, Inc. - Common Stock trades under the ticker ANTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is AN2 Therapeutics, Inc. - Common Stock stock going up?
ANTX has changed by +14.15% over the last week, -3.45% over the last month, and +349.06% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does AN2 Therapeutics, Inc. - Common Stock release financial reports?
Yes. You can track AN2 Therapeutics, Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was AN2 Therapeutics, Inc. - Common Stock net income for the last quarter?
AN2 Therapeutics, Inc. - Common Stock reported net income of -10.03 M for the last quarter. The previous quarter showed -8.71 M, which means net income changed by -15.13%.
How many employees does AN2 Therapeutics, Inc. - Common Stock have?
As of the latest available data, AN2 Therapeutics, Inc. - Common Stock has 21 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy AN2 Therapeutics, Inc. - Common Stock stock?
You can buy AN2 Therapeutics, Inc. - Common Stock (ANTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in AN2 Therapeutics, Inc. - Common Stock stock?
Investing in AN2 Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ANTX chart and related analysis on metatrader.com as part of your research.